Epidemiology of typhoid and paratyphoid fever hospitalizations in Spain (1997-2005)

Human Vaccines

Volumn 5, Issue 6, 2009, Pages 420-424

  Gil, Ruth ^a   Álvarez, Jose Luis ^a   Gómez, Camelia ^a   Álvaro, Alejandro ^a   Gil, Ángel ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Hospitalizations; Spain; Typhoid and paratyphoid fever

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DISEASE SURVEILLANCE; EPIDEMIOLOGICAL DATA; FATALITY; HEALTH CARE COST; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; PARATYPHOID FEVER; SPAIN; TYPHOID FEVER;

EID: 70349529826     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.5.6.8228     Document Type: Article

References (38)

1. WHO Epidemic and Pandemic Alert and Response [consulted 3/10/2008] Avalaible at http://www.who.int/csr/don/2005_01_19/en/index.html.
2. Centers for Disease Control and Prevention CDC [consulted 3/10/2008] Avalaible at http://www.cdc.gov/ncidod/dbmd/diseaseinfo/ TyphoidFever_g.html.
3. Mathura KC, Gurubacharya DL, Shrestha A, Pant S, Basnet P, Karki DB. Clinical profile of typhoid patients. Kathmandu Univ Med J 2003; 1:135-7.
4. Myron ML. Vacunas frente a la fiebre tioidea. In: Plotkin SA, Orenstein WA, Picazo JJ, editors. Vacunas. 4th ed. Madrid: Editorial Médica AWWE 2007; 1099-136.
5. The most dangerous woman in America [consulted 3/10/2008] Available in http://www.pbs.org/wgbh/nova/typhoid/letter.html.
6. Germanier R, Fuer E. Isolation an characterization of gal E mutant Ty21a of Salmonella typhi: a candidate strain for a live oral typhoid vaccine. J Infect Dis 1975; 141:553-8.
7. Parry CM, Hien TT, Dougan G, White N, Farrar J. Typhoid Fever N Eng J Med 2002; 347:1770-82.
8. Levine MM, Ferrecio C, Black RE, Lagos R, San Martin O, Blackwelder WC. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B. Clin Infect Dis 2007; 45:24-8.
9. Tagliabue A, Villa L, De Magistris MT, Romano M, Silvestris S, Boraschi D, et al. IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty21a vaccine. J Immunol 1986; 137:1504-10.
10. Cook FJ, Day M, Wain J, Ward LR, Threlfall EJ. Cases of typhoid fever imported into England, Scotland and Wales (2000-2003) Trans R Soc Trop Med Hyg 2007; 101:398-404.
11. Todd EC. Costs of acute bacterial foodborne disease in Canada and the United States. Int J Food Microbiol 1989; 9:313-26.
12. Ministerio de Ciencia e Innovación. Sistema de Información Microbiológica. [consulted: 06/02/2009] Available at: http://www.isciii.es/jsps/centros/epidemiologia/ informacionMicrobiologica.jsp.
13. Notifiable Diseases Online, Public Health Agency of Canada [consulted 1/ 10/2008] Avalaible at http://dsol-smed.phac-aspc.gc.ca/dsol-smed/ndis/ c_time_e.html.
14. Yohannes K, Roche PW, Roberts A, Liu C, Firestone SM, Bartlett M. Australia's notifiable diseases status, 2004, annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2006; 30:1-79.
15. Ochiai RL, Acosta CJ, Danovaro-Holliday MC, Baiqing D, Bhattacharya SK, Agtini MD, et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ 2008; 86:260-8.
16. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ 2004; 82:346-53.
17. Ferris J, Pérez Aytes A, Cánovas A, Badía J, López C, Orellana F. Salmonella infection in Children. Epidemiological and clinical considerations. An Esp Pediatr 1978; 11:373-82.
18. Hospital Episode Statistics, Department of Health, England, 2002-03 [consulted 1/10/2008] Available at http://www.hesonline.nhs.uk/Ease/ servlet/ContentServer?siteID=1937&categoryID=537.
19. Charifi M, Salehi AA. Retrospective study on the isolated strains of Salmonella in an Iranian hospital in Kermanshah East Mediterr Health J 2006; 12:798-803.
20. Ríos M, García JM, Cubedo M, Pérez D. Time series in the epidemiology of typhoid fever in Spain Med Clin (Barc) 1996; 106:686-9.
21. Ellencweig AY, Slater PE. Demographic and socio-economic patterns of hospitalization for infectious diseases in Israel Eur J Epidemiol 1986; 2:83-9.
22. Bahl R, Sinha A, Poulos C, Whittington D, Sazawal S, Kumar R, et al. Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy. J Health Popul Nutr 2004; 22:304-10.
23. Keller A, Frey M, Schmid H, Steffen R, Walker T, Schlagenhauf P. Imported typhoid fever in Switzerland, 1993 to 2004. J Travel Med 2008; 15:248-51.
24. Caumes E, Ehya N, Nguyen J, Bricaire F. Typhoid and paratyphoid fever: a 10-year retrospective study of 41 cases in a Parisian hospital. J Travel Med 2001; 8:293-7.
25. Antinori S, Galimberti L, Gianelli E, Calattini S, Piazza M, Morelli P. Prospective observational study of fever in hospitalized returning travelers and migrants from tropical areas, 1997-2001. J Travel Med 2004; 11:135-42.
26. Thanassi WT. Immunizations for international travelers. West J Med 1998; 168:197-202.
27. Lin F, Hadle JK. Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era. J Infect Dis 2000; 181:1897-905.
28. Peiro S, Librero J. Evaluación de la calidad a partir del conjunto mínimo de datos básicos al alta hospitalaria. Rev Neurol 1999; 29:651-61.
29. Rivero Cuadrado A. El conjunto mínimo básico de datos en el SNS: Inicios y desarrollo actual. Rev Fuentes Estadísticas 2000; 49:18-9. Available at http://www.webcitation.org/ query.php?url=http://www.fuentesestadisticas.com/Numero49/Paginas/ 18-9.htm&refdoi=10.1186/1471-2458-8-109.
30. Ministerio de sanidad y Consumo. Análisis y desarrollo de los GDR en el Sistema Nacional de Salud. Available at URL: www.msc.es/ estadEstudios/estadisticas/docs/analisis.pdf.
31. Ministerio de Sanidad y Consumo. Clasificación internacional de enfermedades 9 revisión, modificación clínica 1994.
32. Instituto Nacional de la Salud. Subdirección general de coordinación administrativa. Conjunto Mínimo Básico de Datos. Hospitales del INSALUD 2001. Madrid 2002; Available at www.ingesa.msc.es.
33. Sevilla F. La universalización de la atención sanitaria. Sistema Nacional de Salud y Seguridad Social. Fundación Alternativas. Documento de trabajo 86/2006, (Available at URL: www.falternativas.org/base/download/6784_21-06-06_doc86.pdf).
34. Favereau F, Associes, eds. Healthcare Handbook. Vol. 4.2 Spain. 1998-99. Lagon, France 1998; 105-24.
35. Gil A, San-Martin M, Carrasco P, González A. Epidemiology of severe varicella-zoster virus infection in Spain. Vaccine 2004; 22:3947-51.
36. Gil A, Carrasco P, Jimenez R, San-Martin M, Oyagüez I, Gonzalez A. Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999-2000. Vaccine 2004; 22:2221-5.
37. Gil A, San-Martin M, Gil R, Hernandez V, Ribes J, González A. Burden of hospital admissions for Cervical Cancer in Spain During 1999-2002 Hum Vaccin 2007; 3:276-80.
38. Schreyögg J, Stargardt T, Tiemann O, Busse R. Methods to determine reimbursement rates for diagnosis related groups (DRG): a comparison of nine European countries. Health Care Manag Sci 2006; 9:215-23.